Report an error

Spotted something inaccurate in “High Tumor Immune Infiltration Associated with Greater Benefit from BRAF-Targeted Therapy in Melanoma”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.